[Skip to Navigation]
Views 242
Citations 0
Comment & Response
November 12, 2020

Deferring a Change in the Standard of Care for Small Cell Lung Cancer Brain Metastases

Author Affiliations
  • 1Department of Radiation Oncology, New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, New York
JAMA Oncol. 2021;7(1):134-135. doi:10.1001/jamaoncol.2020.5466

To the Editor I commend Rusthoven et al1 for the FIRE-SCLC (First-line Radiosurgery for Small-Cell Lung Cancer) collaborative 3-continent study of up-front stereotactic radiosurgery (SRS) in a large retrospective cohort (n = 710) of patients with small cell lung cancer (SCLC) brain metastases.1 Small cell lung cancer has a higher propensity for intracranial dissemination and shorter central nervous system (CNS) progression interval relative to other malignant neoplasms,2,3 and prophylactic cranial whole brain irradiation decreases brain metastasis development. Therefore, whole-brain radiotherapy (WBRT) is the standard of care for SCLC brain metastases, and SCLC has been excluded from sentinel SRS trials. Results of the FIRE-SCLC study, therefore, greatly inform SCLC SRS.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words